APA (7th ed.) Citation

Luoma, J., Adubra, L., Alber, D., Ashorn, P., Ashorn, U., Cloutman-Green, E., . . . Vehmasto, T. (2023). Statistical analysis plan for the LAKANA trial: A cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali. Trials, 24(1), 1. https://doi.org/10.1186/s13063-023-07771-6

Chicago Style (17th ed.) Citation

Luoma, Juho, et al. "Statistical Analysis Plan for the LAKANA Trial: A Cluster-randomized, Placebo-controlled, Double-blinded, Parallel Group, Three-arm Clinical Trial Testing the Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1–11-month-old Infants in Mali." Trials 24, no. 1 (2023): 1. https://doi.org/10.1186/s13063-023-07771-6.

MLA (9th ed.) Citation

Luoma, Juho, et al. "Statistical Analysis Plan for the LAKANA Trial: A Cluster-randomized, Placebo-controlled, Double-blinded, Parallel Group, Three-arm Clinical Trial Testing the Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1–11-month-old Infants in Mali." Trials, vol. 24, no. 1, 2023, p. 1, https://doi.org/10.1186/s13063-023-07771-6.